Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Charles River Laboratories International Inc

+ Add to Watchlist

CRL:US

79.6301 USD 0.1999 0.25%

As of 11:18:33 ET on 03/31/2015.

Snapshot for Charles River Laboratories International Inc (CRL)

Open: 79.2600 Day's Range: 79.2500 - 79.9000 Volume: 79,587
Previous Close: 79.8300 52wk Range: 49.6000 - 84.6900 1-Yr Rtn: +32.02%

Stock Chart for CRL

No chart data available.
  • CRL:US 79.6900
  • 1D
  • 1M
  • 1Y
79.8300
Interactive CRL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CRL

Current P/E Ratio (ttm) 26.6429
Estimated P/E(12/2015) 22.1256
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 2.9888
Est. EPS (USD) (12/2015) 3.5990
Est. PEG Ratio 2.3783
Market Cap (M USD) 3,768.59
Shares Outstanding (M) 47.33
30 Day Average Volume 523,768
Price/Book (mrq) 5.6036
Price/Sale (ttm) 2.8591
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CRL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CRL

Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company pro- vides the animal research models required in research and development for new drugs, devices, and therapies. Charles River's customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.

James C FosterChairman/President/CEODavid P JohstExec VP:Human Resources/CAO
David SmithSenior VP:Global Discovery SvcsThomas F AckermanExec VP/CFO
More Company Profile & Key Executives for CRL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil